Partilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Revista Portuguesa de Cardiologia
Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
Juan Caro-Codón, Juan R. Rey, Angel M. Iniesta, Sandra O. Rosillo, Sergio Castrejon-Castrejon, Laura Rodriguez-Sotelo, Jose M. Garcia-Veas, Irene Marco, Luis A. Martinez, Lorena Martin-Polo, Carlos Merino, Marcel Martinez-Cossiani, Antonio Buño, Luis Gonzalez-Valle, Alicia Herrero, Esteban López-de-Sá, Jose L. Merino
10.1016/j.repc.2021.06.021
Rev Port Cardiol. 2022;41:823-30
Open access
Takotsubo syndrome in the setting of COVID-19: Pathogenetic and diagnostic implications
Kenan Yalta, Gokay Taylan, Tulin Yalta, Ertan Yetkin
10.1016/j.repc.2021.12.012
Rev Port Cardiol. 2022;41:893-4
Open access
Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
José Silva-Cardoso, Emilia Moreira
10.1016/j.repc.2022.08.006
Rev Port Cardiol. 2022;41:831-2
Open access
The predictive value of epicardial fat volume for clinical severity of COVID-19
Mehmet Akif Erdöl, Fatma Civelek Eser, Abdullah Nabi Aslan, Mehmet Erdoğan, Adalet Altunsoy Aypak, Muhammed Said Beşler, Ayşe Kaya Kalem, Ahmet Göktuğ Ertem, Hatice Rahmet Güner
10.1016/j.repc.2021.05.016
Rev Port Cardiol. 2022;41:729-37
Open access
Epicardial fat as a predictor of COVID-19 disease severity: Just a surrogate for obesity or a true independent predictor?
Christopher Strong
10.1016/j.repc.2022.07.004
Rev Port Cardiol. 2022;41:739-40
Open access
A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists
Dimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, Konstantinos Imprialos, Aristi Boulmpou, Michael Doumas
10.1016/j.repc.2021.10.009
Rev Port Cardiol. 2022;41:705-7
Open access
Myocarditis and COVID-19 mRNA vaccination
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
10.1016/j.repc.2021.08.009
Rev Port Cardiol. 2022;41:727
Open access
Effects of azithromycin on ventricular repolarization in children with COVID-19
Suleyman Sunkak, Mustafa Argun, Binnaz Celik, Onur Tasci, Agah Bahadir Ozturk, Dogan Bahadir Inan, Murat Dogan
10.1016/j.repc.2021.04.008
Rev Port Cardiol. 2022;41:551-6
Open access
Two years later, azithromycin for COVID-19 and the effect on the heart, is it still relevant?
Sérgio Matoso Laranjo
10.1016/j.repc.2022.04.005
Rev Port Cardiol. 2022;41:557-8
Open access
Evaluation of myocardial performance index in patients with COVID-19: An echocardiographic follow-up study
Hakan Kaya, Ramazan Asoglu, Abdulmecit Afsin, Hakan Tibilli, Ercan Kurt, Safiye Kafadar, Umut Gulacti, Huseyin Kafadar
10.1016/j.repc.2021.03.014
Rev Port Cardiol. 2022;41:455-61
Open access
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.